NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)? Did you purchase your shares between ...